Abstract
Since March 2020, the COVID-19 pandemic has increased the influx of severely hypoxemic patients into emergency departments (EDs) all over the world.[1][1] In patients with hypoxemic acute COVID-19 managed in EDs, the most widely used low-flow oxygen therapy to deliver high levels of FIO2 is the non
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
